Publications by authors named "Saniya Virani"

Article Synopsis
  • Activating mutations of FLT3 are linked to uncontrolled growth of hematopoietic stem and progenitor cells in acute myeloid leukemia (AML), contributing to poor patient survival.
  • While treatments targeting mutant FLT3, like Quizartinib and Crenolanib, show promise, patients often develop resistance due to additional mutations and activated survival pathways.
  • Two new FLT3 inhibitors, HSN608 and HSN748, effectively target resistant FLT3 mutations and demonstrate superior anti-leukemic activity compared to the existing FDA-approved drug Gilteritinib.
View Article and Find Full Text PDF

Diploptera punctata, also known as the Pacific beetle cockroach, is a viviparous cockroach that gives birth to live offspring and secretes a highly concentrated mixture of glycosylated proteins as a source of nourishment for developing embryos. These proteins are lipocalins that bind to lipids and crystallize in the gut of the embryo. A structure of milk crystals harvested from the embryos showed that the milk-derived crystals were heterogeneous and made of three proteins (called Lili-Mips).

View Article and Find Full Text PDF

The interaction between G-Protein coupled receptor CXCR4 and its natural ligand CXCL12 has been linked to inflammation experienced by patients with Irritable Bowel Disease (IBD). Blocking this interaction could potentially reduce inflammatory symptoms in IBD patients. In this work, several thiophene-based and furan-based compounds modeled after AMD3100 and WZ811-two known antagonists that interrupt the CXCR4-CXCL12 interaction-were synthesized and analyzed.

View Article and Find Full Text PDF

CXCR4 and its cognate ligand CXCL12 has been linked to various pathways such as cancer metastasis, inflammation, HIV-1 proliferation, and auto-immune diseases. Small molecules have shown potential as CXCR4 inhibitors and modulators, and therefore can mitigate diseases related to the CXCR4-CXCL12 pathway. We have designed and synthesized a series of 2,5-diamino and 2,5-dianilinomethyl pyridine derivatives as potential CXCR4 antagonists.

View Article and Find Full Text PDF